Literature DB >> 11545205

Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia.

N Takahashi1, Y Fujibayashi, Y Yonekura, M J Welch, A Waki, T Tsuchida, N Sadato, K Sugimoto, A Nakano, J D Lee, H Itoh.   

Abstract

Copper-62 labeled diacetyl-bis(N4-methylthiosemicarbazone) (62Cu-ATSM) has been proposed as a generator produced positron-emitting tracer for hypoxic tissue imaging. To clarify the usefulness of 62Cu-ATSM for myocardial ischemia, 62Cu-ATSM PET was performed in 7 patients with coronary artery disease. Increased myocardial uptake of 62Cu-ATSM was observed (myocardium/blood ratio: 3.09) in one patient with unstable angina, who had increased 18F-fluorodeoxyglucose (18F-FDG) uptake under the fasting condition. The other 6 patients, who were clinically stable, did not have increased 62Cu-ATSM uptake, although abnormal 18F-FDG uptake was seen in 4 patients. This preliminary study suggests that 62Cu-ATSM is a promising PET tracer for hypoxic imaging in acute ischemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545205     DOI: 10.1007/bf02987849

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  23 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.

Authors:  Makoto Isozaki; Yasushi Kiyono; Yoshikazu Arai; Takashi Kudo; Tetsuya Mori; Rikiya Maruyama; Ken-ichiro Kikuta; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

3.  Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Authors:  Jason P Holland; Riccardo Ferdani; Carolyn J Anderson; Jason S Lewis
Journal:  PET Clin       Date:  2009-01

Review 4.  Copper promotion of myocardial regeneration.

Authors:  Ying Xiao; Tao Wang; Xin Song; Dan Yang; Qing Chu; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-08

Review 5.  The development of copper radiopharmaceuticals for imaging and therapy.

Authors:  Monica Shokeen; Thaddeus J Wadas
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

6.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

Review 7.  Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).

Authors:  Suzanne E Lapi; Jason S Lewis; Farrokh Dehdashti
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

8.  Positron Emission Tomography Imaging of Hypoxia.

Authors:  Suzanne E Lapi; Thomas F Voller; Michael J Welch
Journal:  PET Clin       Date:  2009-01-01

9.  Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.

Authors:  Xingyu Nie; Gwendalyn J Randolph; Andrew Elvington; Nilantha Bandara; Alexander Zheleznyak; Robert J Gropler; Pamela K Woodard; Suzanne E Lapi
Journal:  Nucl Med Biol       Date:  2016-05-30       Impact factor: 2.408

Review 10.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.